TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
17/06/2026
Voltar para busca
Dado oficial do USPTO
PAIGE APPLAB
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
49
Atualização mais recente
19/06/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
42
Data de depósito
03/11/2021
Data de registro
24/02/2026
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
24/02/2026
Última transação
19/06/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
09/02/2023
Primeiro uso no comércio
09/02/2023
Código do desenho
4
Tipo de titular
03
Localização do titular
New York, NY, US
Examinador
LAW, CHRISTOPHER M
Unidade examinadora
L30
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Paige.AI, Inc.
Representantes
Mark Leonardo NUTTER, MCCLENNEN & FISH, LLP
Classificação técnica
Classes Nice
Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 42
Software as a service (SaaS) services featuring software for use in the analysis of clinical pathology slides using artificial intelligence (AI)machine learningdeep learningstatistical learningdata miningcontextual prediction; medical and scientific testing services for research purposes using artificial intelligence (AI)machine learningdeep learningstatistical learningdata miningcontextual prediction; Software as a service (SaaS) services featuring software for use in disease pathologysoftware that reads digital slides and provides diagnoses; Software as a service (SaaS) services featuring software for use in diagnosisdetectionidentificationdetecting predispositionsdetecting recurrenceevaluation of prognosis and monitoring of diseasesstatesconditions; Software as a service (SaaS) services featuring software to detectmonitorevaluate patients' responses to treatment of diseasesstatesconditions; Software as a service (SaaS) services featuring software for use in clinical managementin the selection of treatment ofuse in prevention ofpalliation or treatmentof diseasesstatesconditions; Software as a service (SaaS) services featuring software for use in research or development in the field of life sciencesmedicinehealthcarecanceroncology and pathology; Software as a service (SaaS) services featuring software to convert patient image data into computer models for medical study of patient anatomyto diagnose medical conditionsto analyze and annotate medical imagesreviewinginterpretingmanaging and navigating digital images of pathology slides prepared from tissue for diagnosing disease statesviewing images and managing analysesfor enabling virtual networks across various pathology departments and pathology laboratories having various laboratory information systems to access the images and analyses; design and development of AI powered computer software that analyzes clinical pathology slides and diagnoses diseases through the use of AI powered computer software; medical and scientific research in the fields of clinical pathology and diseases using AI powered computer software; medical and scientific research and development services in the field of medicinehealthcarecanceroncologylife sciences and pathology; medical and scientific testing services for research purposes; providing medical research and scientific research information in the fields of in vitro diagnostics and clinical pathology research and testing via the internet; and electronic scanning of clinical pathology slide
Publicações
Histórico de despachos e eventos da marca no USPTO.
49 publicações encontradas
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
17/06/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
17/06/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
24/02/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
24/02/2026
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
05/02/2026
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
05/02/2026
SUPC
STATEMENT OF USE PROCESSING COMPLETE
23/12/2025
IUAF
USE AMENDMENT FILED
19/12/2025
EISU
TEAS STATEMENT OF USE RECEIVED
19/12/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/10/2025
EX5G
SOU EXTENSION 5 GRANTED
04/10/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
04/10/2025
EEXT
SOU TEAS EXTENSION RECEIVED
22/05/2025
EXT5
SOU EXTENSION 5 FILED
21/05/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/03/2025
EX4G
SOU EXTENSION 4 GRANTED
03/12/2024
EXT4
SOU EXTENSION 4 FILED
03/12/2024
EEXT
SOU TEAS EXTENSION RECEIVED
03/12/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
13/06/2024
EX3G
SOU EXTENSION 3 GRANTED
03/06/2024
EXT3
SOU EXTENSION 3 FILED
03/06/2024
EEXT
SOU TEAS EXTENSION RECEIVED
03/06/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
30/11/2023
EX2G
SOU EXTENSION 2 GRANTED
29/11/2023
EXT2
SOU EXTENSION 2 FILED
29/11/2023
EEXT
SOU TEAS EXTENSION RECEIVED
29/11/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
29/06/2023
EX1G
SOU EXTENSION 1 GRANTED
27/06/2023
EXT1
SOU EXTENSION 1 FILED
27/06/2023
EEXT
SOU TEAS EXTENSION RECEIVED
27/06/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
03/01/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/11/2022
PUBO
PUBLISHED FOR OPPOSITION
08/11/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
19/10/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/10/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
06/10/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/10/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
06/10/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/10/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
24/08/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
23/08/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
23/08/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
18/08/2022
GNRT
NON-FINAL ACTION E-MAILED
18/08/2022
CNRT
NON-FINAL ACTION WRITTEN
18/08/2022
DOCK
ASSIGNED TO EXAMINER
12/08/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
13/11/2021
NWAP
NEW APPLICATION ENTERED
06/11/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace PAIGE APPLAB ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.